Skip to content

Anesthesia Induction Schemes of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring

To Explore the Influence of Different Anesthesia Induction Schemes on the Quality and Clinical Effect of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05900245
Enrollment
24
Registered
2023-06-12
Start date
2023-06-12
Completion date
2024-08-31
Last updated
2024-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Electroconvulsive Therapy, Electroencephalography

Keywords

Depression,Electroconvulsive Therapy,Electroencephalography

Brief summary

Depression is a common clinical mental disease with high incidence rate, high recurrence rate, high suicide rate and high disability rate. As a first-line treatment for depression with refractory, high suicide risk and obvious psychotic symptoms, electric shock has a definite effect on depression, but may lead to cognitive impairment. The induction of extensive epileptiform discharges in the cerebral cortex by electric shock therapy is the key to ensure the treatment effect. The level of epileptiform discharges in the brain is mainly reflected in the quality of convulsions. The quality of electroconvulsive convulsions is affected by factors such as age, stimulation power, anesthetic drugs and depth of anesthesia. Most anesthetics have anticonvulsive properties, such as barbiturate or propofol, which may have a negative impact on the quality of convulsions, thus affecting the therapeutic effect. If the parameters of electric shock, such as stimulation dose, are modified, although the quality and treatment effect of convulsions can be improved, it may also lead to higher cognitive side effects. The depth of anesthesia also affects the quality and efficacy of electric shock convulsions, and the quality of convulsions is higher when stimulated at a shallow level of anesthesia. However, if the use of narcotic drugs is reduced to improve the quality of convulsions, the risk of restlessness and delirium after electric shock may be higher and the comfort of patients may be lower. Therefore, this study compared the effects of different anesthesia induction schemes on the quality and clinical efficacy of electroconvulsive seizures in patients with depression based on EEG monitoring, and explored the optimal depth of anesthesia.

Detailed description

This study is a randomized controlled, single blind clinical trial comparing the quality of convulsions and clinical effects of electroconvulsive therapy under different levels of consciousness index (IoC).A total of 24 participants were included in this study, all from the inpatient department of the Psychiatric Department of the First Affiliated Hospital of Chongqing Medical University. They were diagnosed as depression patients according to the International Classification of Diseases (ICD-11), and their depression level and cognitive function level were evaluated by trained psychiatrists; In the study, the subjects use the EEG bispectral index monitor (Apollo-9000A) to monitor IoC1(Index of consciousness 1) and IoC2(Index of consciousness 2) before electric shock.Then anesthesia induction was performed using propofol 1.5mg/kg and scoline 1mg/kg. According to the difference in consciousness index 1 (IoC1), the subjects were randomly divided into three groups, namely H group (IoC1 60-70), M group (IoC1 50-60), and L group (IoC1 40-50). All subjects underwent assisted breathing after anesthesia induction, monitoring the concentration of end-expiratory carbon dioxide, and conducting electrical stimulation when the consciousness index reached the corresponding level,and the electrode position is bilateral temporal area. The main outcome measure is EEG seizure duration ,and the secondary outcome measures include average Seizure Energy Index(SEI), electric shock stimulation energy, post-seizure inhibition index, the fastest heart rate, Hamilton Depression Scale (HAMD-24) score, Montreal Cognitive Assessment Scale (MoCA) score, adverse reactions during awakening and the interval between anesthesia induction and the start of electrical stimulation. Due to the varying frequency of electroconvulsive therapy performed by each subject, with an average of 6-12 times and varying duration of each electroconvulsive treatment, this study uses a mixed effects model to analyze the relationship between different consciousness indices and patient factors on the duration of EEG seizures. The depression score and cognitive function score before and after the complete course of electric shock are compared between groups using LSD-t test.

Interventions

OTHERIndex of consciousness+Anesthetic(propofol)+Muscle relaxant(Succinylcholine)

EEG monitoring is performed before induction of electrical shock anesthesia(propofol1.5mg/kg+Succinylcholine1mg/kg), and the timing of electrical stimulation is determined based on the level of consciousness index 1 displayed on the EEG.

Sponsors

Min Su
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Due to the fact that anesthesiologists need to determine the timing of electrical stimulation based on the level of consciousness index during the treatment of electric shock, this study is a randomized controlled, single blind study. The subjects were not aware of their grouping, consciousness index level, and the anesthesiologist was aware of the subjects' consciousness index level, but did not participate in data analysis. The data analyst is not clear about the specific content of the grouping.

Intervention model description

Due to the fact that anesthesiologists need to determine the timing of electrical stimulation based on the level of consciousness index during the treatment of electric shock, this study is a randomized controlled, single blind study.Due to the varying frequency of electroconvulsive therapy performed by each subject, with an average of 6-12 times and varying duration of each electroconvulsive treatment, this study uses a mixed effects model to analyze the relationship between different consciousness indices and patient factors on the duration of EEG seizures.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* In-patients who meet the diagnostic criteria of moderate and severe depression in the 11th edition of the International Classification of Diseases (ICD-11) * Age 18-60 years old, gender unlimited * Primary school or above education level * Indications for MECT treatment * Normal hearing and vision (including color discrimination) * The patient voluntarily participated in the study and signed the informed consent form, and the guardian also signed the informed consent form.

Exclusion criteria

* History of physical disease, brain organic disease and abuse of alcohol and psychoactive substances * Patients with bipolar disorder * Primary insomnia * Combined with other mental diseases * Combined with obesity, diabetes and other metabolic diseases * Combined with hypertension, cardiovascular disease or cerebrovascular disease * Combined with Alzheimer's disease * Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frameDescription
EEG seizure durationup to 30 minutes after each electroconvulsive treatmentDuration of EEG convulsions, in seconds,the most important index of the quality of EEG during the treatment of electric shock

Secondary

MeasureTime frameDescription
electric shock stimulation energyup to 30 minutes after each electroconvulsive treatmentIndicator of electric shock stimulation energy, in mC
post-seizure inhibition indexup to 30 minutes after each electroconvulsive treatmentIndicator of quality of convulsive, in %
Bispectral EEG monitoring indexup to 30 minutes after each electroconvulsive treatmentDepth of sedation and injury stress index,Value range 0-100
Maximun heart rateup to 30 minutes after each electroconvulsive treatmentMaximum heart rate during electrical stimulation,in times/minute
Hamilton scorethrough study completion, an average of 1 yearDepression score,A total score of 81 points, ≤ 8 points without depression, 8-20 points with possible depression, 20-35 points with mild to moderate depression, ≥ 35 points with severe depression
Montreal cognitive scorethrough study completion, an average of 1 yearcognitive function assessment,A total score of 30 points,\<26 points determines the presence of cognitive impairment
average Seizure Energy Index(SEI)up to 30 minutes after each electroconvulsive treatmentIndicator of quality of convulsive, in uV2
Recovery period deliriumup to 4 hours after each electroconvulsive treatmentComplications during anesthesia recovery,Using CAM-ICU scale
Recovery period nausea and vomitingup to 4 hours after each electroconvulsive treatmentComplications during anesthesia recovery,Using index of nausea and vomiting and retching(R-INVR)
Recovery period muscle soreness, headache, dizzinessup to 4 hours after each electroconvulsive treatmentComplications during anesthesia recovery,Using 0 for none, 1 for yes
interval between anesthesia induction and the start of electrical stimulationup to 4 hours after each electroconvulsive treatmentTime to wait for electrical stimulation after administration,in seconds
intraoperative awarenessup to 4 hours after each electroconvulsive treatmentDuring general anesthesia, consciousness recovery occurs, and the patient has a certain degree of perception and memory of the surrounding environment or sound. After general anesthesia, the patient can recall what happened during the surgery and be informed of any pain or other conditions. Events occurring before induction to sleep and after awakening from anesthesia were not included.
Recovery period restlessnessup to 4 hours after each electroconvulsive treatmentComplications during anesthesia recovery,Using Richmond restless sedation scale

Countries

China

Contacts

Primary ContactZhao B shu, MM
bangshuzhao@163.com+8615823079815

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026